1. A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment
   KEI FUJIO et al, 2015, Oncology Reports CrossRef
2. Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
   H Kumon et al, 2016, Cancer Gene Therapy CrossRef
3. A novel in situ permeation system and its utility in cancer tissue ablation
   MASAMI WATANABE, 2015, International Journal of Oncology CrossRef
4. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy
   Tetsuo Oka et al, 2016, Scientific Reports CrossRef
5. Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC following Chemotherapy
   Hiromi Kumon et al, 2015, Clinical Medicine Insights: Oncology CrossRef
6. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression
   RIE KINOSHITA et al, 2015, Oncology Reports CrossRef
7. Study protocol of a Phase I/IIa clinical trial of Ad-SGE-REIC for treatment of recurrent malignant glioma
   Kazuhiko Kurozumi et al, 2020, Future Oncology CrossRef
8. Molecular-Genetic Imaging of Cancer
   Il Minn et al, 2014, Emerging Applications of Molecular Imaging to Oncology CrossRef
9. PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer
   Takamasa Nakasuka et al, 2023, Lung Cancer CrossRef
10. Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells
    Yuhei Horikawa et al, 2017, Oncology Letters CrossRef
11. Robust cancer-specific gene expression by a novel cassette with hTERT and CMV promoter elements
    Masakiyo Sakaguchi et al, 2017, Oncology Reports CrossRef
12. Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3′-side of the transgene
    Endy Widya Putranto et al, 2017, Oncology Letters CrossRef
13. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer
    H Sawahara et al, 2016, Cancer Gene Therapy CrossRef
14. Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
    Yasuhiko Hattori et al, 2022, PLOS ONE CrossRef
15. Killing of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor
    Elena M. Glinka, 2015, Tumor Biology CrossRef
16. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf‐3 expressing adenoviral vector for hepatocellular carcinoma
    Hiroaki Sawahara et al, 2017, Journal of Gastroenterology and Hepatology CrossRef
17. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines
    Yuiko Kato et al, 2017, BMC Veterinary Research CrossRef
18. Regulatory elements in vectors containing the ctEF-1α first intron and double enhancers for an efficient recombinant protein expression system
    Chi-Pin Lee et al, 2018, Scientific Reports CrossRef
19. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity
    Kazuhiko Ochiai et al, 2016, Oncotarget CrossRef
20. Gene Therapy for Prostate Cancer: Current Status and Future Prospects
    Yasutomo Nasu et al, 2018, Hormone Therapy and Castration Resistance of Prostate Cancer CrossRef